In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More
2 years ago
6
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) and BIV201 for Refractory Ascites and HRS-AKI. Visit https://bit.ly/BioVie to learn more.
Loading comments...
-
3:31:12
Price of Reason
11 hours agoThanksgiving Special - Is Stranger Things 5 any good and other SURPRISES!
109K1 -
14:14
Robbi On The Record
7 hours ago $2.79 earnedThe Identity Crisis No One Wants to Admit | Identity VS. Personality
8.92K2 -
31:10
The Why Files
4 days agoThe First Earth Battalion: America's Strangest Military Experiment
54.8K26 -
4:18:02
SpartakusLIVE
8 hours ago#1 Pilgrim of PAIN Gives Thanks HAPPILY as he DESTROYS Enemies and BAGS LOOT
171K7 -
59:47
iCkEdMeL
8 hours ago $37.00 earnedBREAKING: National Guard Soldier Dies + New Video Shows Suspect Opening Fire
34.5K39 -
1:20:38
Flyover Conservatives
1 day agoThanksgiving’s Hidden History: Islamic Pirates, Spanish Threats, and Socialism - Bill Federer | FOC Show
40.4K3 -
25:43
Russell Brand
1 day agoThis Is Getting Out Of Hand
136K150 -
LIVE
The Quartering
16 hours agoThanksgiving Day Yule Log!
1,538 watching -
15:32
IsaacButterfield
1 day ago $5.79 earnedAussie Reacts To UNHINGED Woke TikToks!
30.5K11 -
3:24:28
PandaSub2000
17 hours agoNintendo Platformers - Thanksgiving 2025 Special | ULTRA BEST AT GAMES (Original Live Version)
48.9K8